EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)

Sergio Todde, Albert D. Windhorst, Martin Behe, Guy Bormans, Clemens Decristoforo, Alain Faivre-Chauvet, Valentina Ferrari, Antony D. Gee, Balazs Gulyas, Christer Halldin, Petra Kolenc Peitl, Jacek Koziorowski, Thomas L. Mindt, Martina Sollini, Johnny Vercouillie, James R. Ballinger, Philip H. Elsinga

Research output: Contribution to journalArticlepeer-review


The preparation of an Investigational Medicinal Product Dossier (IMPD) for a radiopharmaceutical to be used in a clinical trial is a challenging proposition for radiopharmaceutical scientists working in small-scale radiopharmacies. In addition to the vast quantity of information to be assembled, the structure of a standard IMPD is not well suited to the special characteristics of radiopharmaceuticals. This guideline aims to take radiopharmaceutical scientists through the practicalities of preparing an IMPD, in particular giving advice where the standard format is not suitable. Examples of generic IMPDs for three classes of radiopharmaceuticals are given: a small molecule, a kit-based diagnostic test and a therapeutic radiopharmaceutical.

Original languageEnglish
Pages (from-to)2175-2185
Number of pages11
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Issue number11
Publication statusPublished - 2014


  • Clinical trial
  • Guideline
  • Investigational medicinal product
  • Radiopharmaceutical

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)


Dive into the research topics of 'EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)'. Together they form a unique fingerprint.

Cite this